Medical Condition News

RSS

Researchers find no evidence of protective link between soy food and endometrial cancer risk

Researchers have found no evidence of a protective association between soy food and endometrial cancer risk, says a new study published (18 June) in BJOG: An International Journal of Obstetrics and Gynaecology.

18 Jun 2014

Women more likely than men to use tobacco products after experiencing psychological distress

A new study in the American Journal of Health Behavior finds that women are more likely than men to use tobacco products after experiencing severe psychological distress.

18 Jun 2014

Stress may accelerate cognitive decline later in life

A new study published in the June 18 issue of The Journal of Neuroscience adds to a body of evidence suggesting stress may accelerate cognitive decline later in life.

18 Jun 2014

Tax on sweetened soft drinks could be effective weapon in war against obesity

A tax on sweetened soft drinks could be an effective weapon in the war against obesity, generating weight losses of up to 3.64 kilograms as individuals reduce their consumption.

18 Jun 2014

Single dose restores normal cellular signaling in mouse model of autism

In a further test of a novel theory that suggests autism is the consequence of abnormal cell communication, researchers at the University of California, San Diego School of Medicine report that an almost century-old drug approved for treating sleeping sickness also restores normal cellular signaling in a mouse model of autism, reversing symptoms of the neurological disorder in animals that were the human biological age equivalent of 30 years old.

18 Jun 2014

BIPI, Lilly announce resubmission of empagliflozin NDA to FDA for treatment of type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the resubmission of a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults with type 2 diabetes (T2D) to the U.S. Food and Drug Administration (FDA).

17 Jun 2014

Evolution of multiple sclerosis treatments: an interview with Mike Panzara, Head of MS & Neurology Clinical Development, Genzyme

The last 20 years have been defined by progress and innovation in the multiple sclerosis (MS) field, with now 10 approved treatment options available for people living with relapsing MS, the most common form of the disease.

17 Jun 2014

New hope for people suffering from depression

There is new hope for people suffering from depression. Researchers have identified a compound, hydroxynorketamine (HNK), that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study in the July issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists- (ASA-).

17 Jun 2014

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

17 Jun 2014

Autistic-like behaviors linked with disruption of Adenomatous Polyposis Coli gene

Autistic-like behaviors and decreased cognitive ability may be associated with disruption of the function of the Adenomatous Polyposis Coli (APC) gene.

17 Jun 2014

Low-power sensor to track changes in eye pressure for management of glaucoma

Your eye could someday house its own high-tech information center, tracking important changes and letting you know when it's time to see an eye doctor.

17 Jun 2014

Signaling pathway may help explain why body clocks of people with bipolar disease

Alterations in a cellular signaling pathway called cAMP-CREB may help explain why the body clocks of people with bipolar disease are out of sync, according to a new European Journal of Neuroscience study.

17 Jun 2014

Lowering systolic blood pressure below 120 does not appear to provide additional benefit

For decades, common medical wisdom has been "the lower the better" in treating the approximately one in three people in this country who have high blood pressure.

17 Jun 2014

Tips to help kids enjoy healthy, symptom-free days in classroom and on sports field

Your kids may be enjoying the lazy days of summer, but if they have asthma, allergies - or both - they need to be prepared for back-to-school. And so do their classrooms. More than 10 million kids under age 18 have asthma, and 11 percent suffer from respiratory allergies. About 6 percent have also been diagnosed with food allergies.

17 Jun 2014

New investigational drug can slow memory loss in older Individuals with risk for developing AD in future

A new research study at Rush University Medical Center and Northwestern Medicine is testing whether a new investigational treatment can slow the memory loss caused by Alzheimer's disease.

17 Jun 2014

Cryoprobes better than conventional forceps for performing lung biopsies

A randomized controlled trial has found that cryoprobes, which are tools that apply extreme cold to tissues, are better than conventional forceps for performing so-called transbronchial lung biopsies in patients who are being assessed for certain lung conditions.

17 Jun 2014

Study: Use of stem cells to regenerate heart muscle in patients who have heart attacks

Stem cell therapy for cardiovascular disease isn't a medical pipe dream - it's a reality today, although patients need to better understand the complex science behind these experimental treatments, according to the chief of Cardiology for the Cedars-Sinai Heart Institute.

17 Jun 2014

Provepharm, DFKC partner to launch Methylthioninium chloride Proveblue in Germany

Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm’s drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.

17 Jun 2014

Discovery may lead to new treatments for common autoimmune diseases

Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system.

17 Jun 2014

International researchers discover genetic component of Idiopathic Generalized Epilepsy

An international team of researchers has discovered a significant genetic component of Idiopathic Generalized Epilepsy (IGE), the most common form of epilepsy.

17 Jun 2014

Medical Condition News

Researchers find no evidence of protective link between soy food and endometrial cancer risk

Women more likely than men to use tobacco products after experiencing psychological distress

Stress may accelerate cognitive decline later in life

Tax on sweetened soft drinks could be effective weapon in war against obesity

Single dose restores normal cellular signaling in mouse model of autism

BIPI, Lilly announce resubmission of empagliflozin NDA to FDA for treatment of type 2 diabetes

Evolution of multiple sclerosis treatments: an interview with Mike Panzara, Head of MS & Neurology Clinical Development, Genzyme

New hope for people suffering from depression

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Autistic-like behaviors linked with disruption of Adenomatous Polyposis Coli gene

Low-power sensor to track changes in eye pressure for management of glaucoma

Signaling pathway may help explain why body clocks of people with bipolar disease

Lowering systolic blood pressure below 120 does not appear to provide additional benefit

Tips to help kids enjoy healthy, symptom-free days in classroom and on sports field

New investigational drug can slow memory loss in older Individuals with risk for developing AD in future

Cryoprobes better than conventional forceps for performing lung biopsies

Study: Use of stem cells to regenerate heart muscle in patients who have heart attacks

Provepharm, DFKC partner to launch Methylthioninium chloride Proveblue in Germany

Discovery may lead to new treatments for common autoimmune diseases

International researchers discover genetic component of Idiopathic Generalized Epilepsy

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News